16430-1 |
Barbiturates |
ACnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Barbiturates [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16430-1 |
|
|
|
|
Both |
|
|
|
0 |
Barbiturates Ur-aCnc |
|
|
|
Y |
|
Addiction; Arbitrary Concentration; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16431-9 |
Barium |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Barium [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16431-9 |
|
|
|
|
Both |
|
|
|
0 |
Barium Ur Ql |
|
|
|
|
|
Ba; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16432-7 |
Barium |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Barium [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
16432-7 |
|
|
|
|
Both |
|
|
|
0 |
Barium Bld-mCnc |
|
|
|
Y |
|
Ba; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
16433-5 |
Basement membrane Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Basement membrane Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
16433-5 |
|
|
|
|
Both |
|
|
|
0 |
BM Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basem; Basemt; BM; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16434-3 |
Basement membrane Ab |
ACnc |
Ser |
Pt |
Qn |
IF |
|
ACTIVE |
Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
16434-3 |
|
IF |
|
|
Both |
|
|
|
0 |
BM Ab Ser IF-aCnc |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Basem; Basemt; BM; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
16435-0 |
Bean white Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated White Bean IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
16435-0 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated White Bean IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Beans; Cannellini bean; f015; f15; Immune globulin E; Immunoglobulin E; Navy bean; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; White Bean; White kidney bean |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16436-8 |
Bean wax Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Bean string IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
16436-8 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Wax Bean IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Beans; Immune globulin E; Immunoglobulin E; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; String bean; Wax Bean |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16437-6 |
Bendroflumethiazide |
ACnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Bendroflumethiazide [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16437-6 |
|
|
|
|
Both |
|
|
|
0 |
Bendroflumethiaz Ur-aCnc |
|
|
|
Y |
|
Aprinox; Arbitrary concentration; Bendrofluazide; Benzide; Berkozide; Centyl; DRUG/TOXICOLOGY; Drugs; Esbericid; Naturetin; Naturine; Neo-naclex; PLURYL; Point in time; QNT; Quan; Quant; Quantitative; Random; Salures; Sinesalin; UA; UR; Urn |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16438-4 |
Benzaldehyde |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Benzaldehyde [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16438-4 |
|
|
|
|
Both |
|
|
|
0 |
Benzaldehyde Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16439-2 |
Benzene |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Benzene [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16439-2 |
|
|
|
|
Both |
|
|
|
0 |
Benzene Bld Ql |
|
|
|
|
|
Blood; Cyclohexatriene; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1644-4 |
Triglyceride^post 12H CFst |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1644-4 |
|
|
|
|
Both |
|
|
|
0 |
Trigl p 12h fast SerPl-mCnc |
|
|
|
Y |
|
After; Calorie Fast; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; Heart Disease; Level; Mass concentration; p 12h fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Trig; Trigly; Triglycerides; Triglycrides |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
16440-0 |
Benzene ring Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Benzene ring IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
16440-0 |
|
|
|
|
Both |
|
|
|
0 |
Benzene ring IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cyclohexatriene; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
16441-8 |
Benzene ring Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Benzene ring IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
16441-8 |
|
|
|
|
Both |
|
|
|
0 |
Benzene ring IgG Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cyclohexatriene; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
16442-6 |
Benzene ring Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Benzene ring IgM Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
16442-6 |
|
|
|
|
Both |
|
|
|
0 |
Benzene ring IgM Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cyclohexatriene; Immune globulin M; Immunoglobulin M; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
16443-4 |
Benzonatate |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Benzonatate [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
16443-4 |
|
|
|
|
Both |
|
|
|
0 |
Benzonatate Ser-mCnc |
|
|
|
Y |
|
Addiction; C30H53NO11; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tessalon |
2.42 |
1.0l |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
16444-2 |
Benzophenone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Benzophenone [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16444-2 |
|
|
|
|
Both |
|
|
|
0 |
Benzophenone SerPl-mCnc |
|
|
|
Y |
|
Alpha-oxodiphenylmethane; Alpha-oxoditane; Benzoylbenzene; C13H10O; Diphenyl ketone; Diphenylmethanone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oxodiphenylmethane; Oxoditane; Phenyl ketone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
16446-7 |
Benzoylecgonine |
PrThr |
Ser/Plas |
Pt |
Ord |
Confirm |
|
ACTIVE |
Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16446-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
BZE SerPl Ql Cfm |
|
|
|
|
|
BEC; BEG; Benz; Benzoylec; BZE; Cfm; CNFR; CNFRM; Cocaine degradation production; Cocaine metabolite; Conf; Confirmation; Confirmatory; Crack metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16447-5 |
Cocaine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Cocaine [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16447-5 |
|
|
|
|
Both |
|
|
|
0 |
Cocaine SerPl-aCnc |
|
|
|
Y |
|
Addiction; Arbitrary Concentration; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Snow; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16448-3 |
Cocaine |
ACnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Cocaine [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16448-3 |
|
|
|
|
Both |
|
|
|
0 |
Cocaine Ur-aCnc |
|
|
|
Y |
|
Addiction; Arbitrary Concentration; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Snow; UA; UR; Urn |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16449-1 |
Benzthiazide |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Benzthiazide [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16449-1 |
|
|
|
|
Both |
|
|
|
0 |
Benzthiazide SerPl-mCnc |
|
|
|
Y |
|
Diurin; DRUG/TOXICOLOGY; Drugs; Exna; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
1645-1 |
Xylose^2H post 25 g xylose PO |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1645-1 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 2h p 25 g Xyl PO Bld-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 25 g Xyl PO; After; Blood; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; Mass concentration; p 25 g Xyl PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Xylose absorption test |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
16450-9 |
Benzylhydrazine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Benzylhydrazine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16450-9 |
|
|
|
|
Both |
|
|
|
0 |
Benzylhydrazine SerPl-mCnc |
|
|
|
Y |
|
C7H10N2; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
16451-7 |
Beryllium |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Beryllium [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
16451-7 |
|
|
|
|
Both |
|
|
|
0 |
Beryllium Ur Ql |
|
|
|
|
|
Be; Berylliosis; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16452-5 |
Beta alanine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Beta alanine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16452-5 |
|
|
|
|
Observation |
|
|
|
0 |
B-Alanine Ur Ql |
|
|
|
|
|
Ala; Alpha alanine; B; Bala; B-Ala; B-Alanine; Chemistry; L-alanine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16453-3 |
Beta aminoisobutyrate |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Beta aminoisobutyrate [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16453-3 |
|
|
|
|
Observation |
|
|
|
0 |
B-AIB Ur Ql |
|
|
|
|
|
3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |